Grand Rounds công khai
[search 0]
Thêm

Download the App!

show episodes
 
Grand Rounds, a staple of American medical education for more than 100 years, spans every field of clinical practice. It is a master class on the art and science of medicine, delivered by renowned clinicians in academic settings nationwide. Yet in today's practice, where time is an all-too precious commodity, regular attendance at Grand Rounds sessions has become increasingly difficult. In response to this challenge, ReachMD brings the lecture hall to you, with these outstanding talks from t ...
 
As part of our mission to end cardiovascular disease, The Minneapolis Heart Institute Foundation offers weekly cardiology Grand Rounds to stay up-to-date on the latest developments in cardiology. These weekly meetings feature topics from the following cardiac specialty areas: congestive heart failure, electrophysiology, cardiac imaging, interventional cardiology, heart disease prevention, cardiac surgery, vascular/endovascular and miscellaneous.
 
Lectures and discussions to help meet the continuing education needs of physicians and other healthcare professionals involved in neonatal, cardiology, pediatric, obstetric and maternal-fetal medicine. These podcasts are presented through Pediatrix University by the The Center for Research, Education and Quality.The Grand Rounds forum provides topics in neonatal-perinatal medicine. Educational activities offer a combined slide and audio presentation, as well as mp3, mp4, and a non-audio opti ...
 
Loading …
show series
 
Nathan T. Smith, PharmD, BCPS recalls the clinical presentation of gender incongruence, identifies current treatment options for transgender men and women and describes potential cardiovascular risks associated with gender-affirming hormone therapy. For more pharmacy content, follow Mayo Clinic Pharmacy Residency Programs @MayoPharmRes or the host,…
 
Mikaela Hofer, Pharm.D., BSPS, BCCCP (@mikaelamhofer) identifies limitations of current vasopressor agents for the treatment of septic shock, reviews novel vasopressor therapies with a current or potential role in the management of septic shock and describes advancements in the development of biomarkers and pharmacogenomics for the monitoring and i…
 
Allison Golbach, PharmD, BCPS (@AllisonGPharmD) describes epidemiology, pathophysiology, and prognosis of acute myeloid leukemia (AML), reviews literature supporting induction regimens for patients with AML without targetable mutations and discusses how to select between AML induction regimens based on patient-specific factors. For more pharmacy co…
 
Nicole Hlavacek, PharmD (@HlavacekPharmD) recognizes the proposed mechanism of magnesium in different pathologies, recalls dosing and administration rates for magnesium and describes effectiveness of magnesium. For more pharmacy content, follow Mayo Clinic Pharmacy Residency Programs @MayoPharmRes or the host, Garrett E. Schramm, Pharm.D., @garrett…
 
Hannah Poppen, PharmD (@PoppenPharmD) reviews guideline recommendations for management of blood cholesterol, describes the risks and benefits associated with adjunct non-statin therapy and identifies patient-specific characteristics in which PCSK9 inhibitor therapy should be considered. For more pharmacy content, follow Mayo Clinic Pharmacy Residen…
 
Nicholas Vollmer, PharmD (@VollmerNick) describes the mechanism through which thromboelastography works and how it differs from current assessments of coagulation, identifies patient scenarios where thromboelastography may be of benefit compared to standard of care and discovers barriers of widespread use of thromboelastography. For more pharmacy c…
 
Yen Tran, PharmD, MBA (@YenTranlt) illustrates the consequences of antibody mediated rejection (AMR) on solid organ transplant recipients, develops a management strategy for AMR and outlines approaches to AMR management. For more pharmacy content, follow Mayo Clinic Pharmacy Residency Programs @MayoPharmRes or the host, Garrett E. Schramm, Pharm.D.…
 
Mikhaila Rice, PharmD, BCPS (@MikhailaPharmD) reviews pathophysiology of gastrointestinal stromal tumors, describes the pharmacology of medications used to treat gastrointestinal stromal tumors and discusses the place in therapy of new treatment options, including ripretinib and avapritinib. For more pharmacy content, follow Mayo Clinic Pharmacy Re…
 
Laurel Lake, PharmD (@laurel_pharmd) outlines the guideline recommendations for duration of antiplatelet therapy in acute coronary syndrome in patients using anticoagulation for atrial fibrillation, reviews recent literature examining antiplatelet therapy in patients with atrial fibrillation and stable coronary artery disease and discusses the bala…
 
Dylan Kosaski, PharmD (@Dylan_Kosaski) identifies the purpose of 340B and the impact on health care costs, evaluates the role of 340B contract pharmacies and reviews challenges facing the 340B program and potential consequences. For more pharmacy content, follow Mayo Clinic Pharmacy Residency Programs @MayoPharmRes or the host, Garrett E. Schramm, …
 
Kellyn Engstrom, PharmD, MPH (@KellynEPharmD) lists three differences between COVID-19 immunization efforts and previous mass immunization strategies, describes challenges in complying with vaccine delivery, storage, and administration processes required by FDA emergency use authorization and summarizes the current state and future directions of CO…
 
Jennifer Adema, PharmD, MBA (@JAdemaPharmD) describes remdesivir’s mechanism of action against SARS-CoV-2, identifies optimal adult patient populations for remdesivir and outlines future directions for remdesivir in COVID-19 treatment. For more pharmacy content, follow Mayo Clinic Pharmacy Residency Programs @MayoPharmRes or the host, Garrett E. Sc…
 
Andrew Webb, Pharm.D. (@AJWPharm) describes the pharmacokinetic alterations of critical illness and the implications for beta-lactam optimization, recognizes the potential role of beta-lactam therapeutic monitoring in predicting drug effectiveness, and identifies the potential role of beta-lactam therapeutic monitoring in recognizing drug toxicity.…
 
Hannah Brokmeier, Pharm.D. (@hannahbrokmeier) discusses the role of MRAs in patients with ESRD, reviews the literature concerning risks and benefits of MRAs in patients with ESRD, and outlines a potential MRA treatment regimen for a patient with dialysis-dependent ESRD. For more pharmacy content, follow Mayo Clinic Pharmacy Residency Programs @Mayo…
 
Kyle Wamsley, Pharm.D. (@KyleWamsley1) discusses current literature surrounding the use of oral antimicrobials in the treatment of infective endocarditis (IE), identifies specific patient populations in whom it may be appropriate to consider oral therapy for the treatment of IE, and outlines oral antimicrobial regimens which may be most appropriate…
 
Ashley Otto, Pharm.D., BCPS describes the pathophysiology of non-pulmonary clinical manifestations in cystic fibrosis (CF), reviews guideline recommendations and primary literature to manage non-pulmonary CF complications, and selects appropriate treatment options for patients with non-pulmonary CF complications. For more pharmacy content, follow M…
 
Cassandra Schmitt, Pharm.D. (@cjschmitt2) describes the differences between thrombolytic agents used for the treatment of ischemic stroke, discusses the literature examining the efficacy and safety outcomes of tenecteplase, and identifies the role of tenecteplase in ischemic stroke thrombolysis. For more pharmacy content, follow Mayo Clinic Pharmac…
 
Shannon Piche, Pharm.D., BCPS describes the incidence and clinical manifestation of PICS, reviews literature examining the long term implications of critical illness, and discusses current strategies to address care gaps related to PICS symptom recognition and management. For more pharmacy content, follow Mayo Clinic Pharmacy Residency Programs @Ma…
 
Allison Golbach, Pharm.D., BCPS (@AllisonGPharmD) reviews the definition, background, and measurement of financial toxicity, discusses the impact of financial toxicity on patients’ clinical outcomes, and identifies methods to help patients make informed decisions about their oncology care. For more pharmacy content, follow Mayo Clinic Pharmacy Resi…
 
Kellyn Engstrom, Pharm.D., MPH (@KellynEPharmD) reports on current guideline recommendations and gaps in evidence for the treatment of status epilepticus, interprets recent evidence regarding conventional antiepileptic utilization in status epilepticus, and lists three considerations in applying new evidence for status epilepticus treatment into cl…
 
Mikhaila Rice, Pharm.D., BCPS (@MikhailaPharmD) reviews chronic lymphocytic leukemia diagnosis and historical treatment options, describes the pharmacology of Bruton tyrosine kinase inhibitors and venetoclax, and discusses the use of targeted agents as first line therapy for chronic lymphocytic leukemia. For more pharmacy content, follow Mayo Clini…
 
Madison Fazio, Pharm.D. (@madison_fazio) discusses new guideline recommendations for the management of gout, reviews the literature contributing to the new gout recommendations, and recognizes patients that would benefit from newer gout therapies based on guideline recommendations. For more pharmacy content, follow Mayo Clinic Pharmacy Residency Pr…
 
Natalie Haddad, Pharm.D. (@NatalieHaddadRx) explains the mechanism of action of midodrine, reviews the current evidence for midodrine and its impact on vasopressor discontinuation and identifies midodrine’s role in therapy for vasopressor discontinuation. For more pharmacy content, follow Mayo Clinic Pharmacy Residency Programs @MayoPharmRes or the…
 
Danielle Hess, Pharm.D. (@dhess_09) describes the potential effects of bariatric surgery on drug pharmacotherapy measures due to altered gastrointestinal anatomy, reviews literature pertaining to warfarin use after bariatric surgery and discusses safety and efficacy of direct-acting oral anticoagulants (DOACs) following bariatric surgery. For more …
 
Nicholas Vollmer, Pharm.D. (@VollmerNick) discusses pharmacological characteristics of tranexamic acid, compares and contrasts primary literature for proposed tranexamic acid indications and identifies pharmacotherapy pearls related to tranexamic acid. For more pharmacy content, follow Mayo Clinic Pharmacy Residency Programs @MayoPharmRes or the ho…
 
Jamie Reed, Pharm.D., BCPS, recalls the pathophysiology of anaphylaxis, differentiates pharmacological options for prevention of anaphylaxis and determines effective acute pharmacological and non-pharmacological management of anaphylaxis. For more pharmacy content, follow Mayo Clinic Pharmacy Residency Programs @MayoPharmRes or the host, Garrett E.…
 
Sarah Stieven, Pharm.D. reviews the pathophysiology of cystinuria, describes non-pharmacologic and pharmacologic treatment options for cystinuria and reviews potential side effects of pharmacologic options of cystinuria and how to manage For more pharmacy content, follow Mayo Clinic Pharmacy Residency Programs @MayoPharmRes or the host, Garrett E. …
 
Joseph Zieminski, Pharm.D. observed in the obese population, discusses pharmacokinetic changes and outcomes data of direct oral anticoagulants (DOACs) in obese patients and selects an appropriate DOAC for use in an obese patient case. For more pharmacy content, follow Mayo Clinic Pharmacy Residency Programs @MayoPharmRes or the host, Garrett E. Sch…
 
Joseph Osborne II, Pharm.D. (@JOzempic) describes the pharmacology of the gabapentinoids, reviews literature pertaining to perioperative gabapentinoid use for acute pain management and identifies toxicity, misuse, and abuse considerations relating to gabapentinoid use. For more pharmacy content, follow Mayo Clinic Pharmacy Residency Programs @MayoP…
 
Jennifer Adema, Pharm.D., M.B.A. (@JAdemaPharmD) identifies different strains of bacteria found in probiotics, discusses target populations for probiotic use and describes the use of probiotics in immunocompromised patients. For more pharmacy content, follow Mayo Clinic Pharmacy Residency Programs @MayoPharmRes or the host, Garrett E. Schramm, Phar…
 
Lindsay Moreland-Head, Pharm.D. (@morelandln) describes the pathophysiology of intravascular versus tissue congestion in Acute Decompensated Heart Failure (ADHF), explains the mechanisms of diuretic resistance in ADHF and why non-inotropic strategies may help augment diuresis and discusses the literature on non-inotropic strategies to decongest pat…
 
Deann Tims, Pharm.D. will describe the pathiophysiology and complications associate with sickle cell disease, review standard treatment modalities of sickle cell disease and discuss recent literature regarding advancements in sickle cell disease therapy. For more pharmacy content, follow Mayo Clinic Pharmacy Residency Programs @MayoPharmRes or the …
 
Kellyn K. Engstrom, Pharm.D., (@KellynEPHarmD) discusses evidence for efficacy of tramadol for indications of acute or chronic pain in adults, describes major safety and pharmacokinetic considerations for the utilization of tramadol and assesses the current misuse and abuse potential of tramadol. For more pharmacy content, follow Mayo Clinic Pharma…
 
Nicholas J. Vollmer, Pharm.D., (@VollmerNick) describes the background of penicillin allergies, discusses consequences associated with mislabeled penicillin allergies and identifies strategies institutions can employ to combat the mislabeled penicillin allergies. For more pharmacy content, follow Mayo Clinic Pharmacy Residency Programs @MayoPharmRe…
 
Victoria R. Milano, Pharm.D., BCPS, (@VMilanoPharmD) describes the mechanism of immune checkpoint inhibitor and CAR T-cell therapy toxicities, reviews the most common types of toxicities and risk factors associated with immunotherapy treatments and discuss literature and guideline recommendations for the management of immunotherapy toxicities. For …
 
Alex B. Wontor, Pharm.D., reviews treatment strategies for the acute symptomatic presentation in thyroid storm, discusses pharmacological treatment for the reduction of thyroid hormone synthesis and describes the long term management of patients that present in thyroid storm to prevent recurrence. For more pharmacy content, follow Mayo Clinic Pharm…
 
Abby K. Hendricks, Pharm.D., (@HendricksPharmD) identifies risk factors for the development of delirium, discusses literature assessing the use of antipsychotics for delirium in various patient populations and describes treatment options for managing delirious patients. For more pharmacy content, follow Mayo Clinic Pharmacy Residency Programs @Mayo…
 
Catherine DeFino, Pharm.D., (@catherinedefino) describes the epidemiology of childhood cancers, discusses late effects of commonly utilized treatments and reviews management strategies for late effects of childhood cancer. For more pharmacy content, follow Mayo Clinic Pharmacy Residency Programs @MayoPharmRes or the host, Garrett E. Schramm, Pharm.…
 
Jade L. Kutzke, Pharm.D., (@kutzke_jade) summarizes the pathophysiology of acquired thrombotic thrombocytopenic purpura, outlines the current aTTP treatment pathway and identifies caplacizumab’s role in the current treatment approach of aTTP. For more pharmacy content, follow Mayo Clinic Pharmacy Residency Programs @MayoPharmRes or the host, Garret…
 
Mikaela M. Hofer, Pharm.D., (@mikaelamhofer) identifies risk factors associated with postpartum depression, reviews current options for treatment and describes the potential place in therapy for brexanolone in treating postpartum depression. For more pharmacy content, follow Mayo Clinic Pharmacy Residency Programs @MayoPharmRes or the host, Garrett…
 
Casey R. O'Connell, Pharm.D., CPS reviews potential toxicities associated with an acute SSRI overdose, identifies pharmacological interventions used to treat patients with acute SSRI overdose and reviews a patient case pertaining to the management of an acute SSRI overdose. For more pharmacy content, follow Mayo Clinic Pharmacy Residency Programs @…
 
Hannah Sauer, Pharm.D. describes the challenges in acute medical management of patients with cerebral palsy, lists special considerations for drug therapy in patients with CP and identifies the optimal approach to pain and sedation in patients with CP. For more pharmacy content, follow Mayo Clinic Pharmacy Residency Programs @MayoPharmRes or the ho…
 
Mikhaila L. Rice, Pharm.D., (@MikhailaPharmD) explains the difference between pre-emptive and prophylaxis strategies for cytomegalovirus infection prevention, selects patients that may benefit from letermovir prophylaxis based on existing literature, and identifies areas of investigational use of letermovir. For more pharmacy content, follow Mayo C…
 
Allison P. Golbach, Pharm.D., (@AllisonGPharmD) describes mechanisms of action of medical marijuana in pain relief, reviews the evidence for use of medical marijuana in chronic pain management and medication management considerations for patients using medical marijuana. For more pharmacy content, follow Mayo Clinic Pharmacy Residency Programs @May…
 
Andrew J. Webb, Pharm.D., (@AJWPharm) describes the pathophysiology of myasthenia gravis and how certain antibiotics interact with the disease, outlines available literature investigating the clinical effects and monitoring of antibiotic use in myasthenia gravis, and how to select a safe and effective treatment plan for a patient with myasthenia gr…
 
Linda Huang, Pharm.D., (@lindaleqi) describes the potential effects of abnormal levels of select vitamins/minerals, discusses recent literature on supplementation of selected vitamins/minerals and the potential drug-nutrient interactions with commonly prescribed medications. For more pharmacy content, follow Mayo Clinic Pharmacy Residency Programs …
 
Abby K. Hendricks, Pharm.D., (@HendricksPharmD) reviews strategies to mitigate the risk of gastrointestinal bleeds (GIB) with antithrombotics, shares literature assessing management of antithrombotic therapy after a bleeding event, and designs a treatment plan for appropriate re-initiation of anticoagulants and antiplatelets following GIB. For more…
 
Coming soon! A new podcast from Mayo Clinic Talks Productions: Mayo Clinic Pharmacy Grand Rounds is a weekly podcast for pharmacists, physicians, physician assistants, and nurse practitioners who are interested in learning more about clinical pharmacology topics. For more information, to claim pharmacology CE credit, or to get a copy of presentatio…
 
#1 AI and Evidence-Based Medicine Advertisements __ATA.cmd.push(function() { __ATA.initSlot('atatags-26942-5c92968cc9ba1', { collapseEmpty: 'before', sectionId: '26942', width: 300, height: 250 }); }); __ATA.cmd.push(function() { __ATA.initSlot('atatags-114160-5c92968cc9ba4', { collapseEmpty: 'before', sectionId: '114160', width: 300, height: 250 }…
 
Discover how hearing loss in the US is growing and how it affects young and older people alike. Protect your patients' hearing with these tips and resources in an increasingly noisy world from Dr. John Iskander and Dr. William Murphy in this session of Beyond the Data. Visit Dangerousdecibels.org to learn how to protect your hearing. Discover “How …
 
Loading …

Hướng dẫn sử dụng nhanh

Google login Twitter login Classic login